Alcami J, Joseph Munne J, Munoz-Fernandez M, Esteban M
Enferm Infecc Microbiol Clin. 2024; 23:15-24.
PMID: 38620211
PMC: 7130212.
DOI: 10.1016/S0213-005X(05)75157-0.
Perez-Yanes S, Pernas M, Marfil S, Cabrera-Rodriguez R, Ortiz R, Urrea V
Front Microbiol. 2022; 13:763039.
PMID: 35401460
PMC: 8988142.
DOI: 10.3389/fmicb.2022.763039.
Okamura T, Shimizu Y, Asaka M, Kanuma T, Tsujimura Y, Yamamoto T
NPJ Vaccines. 2021; 6(1):124.
PMID: 34686680
PMC: 8536741.
DOI: 10.1038/s41541-021-00386-5.
Fok J, Mayer C
Chembiochem. 2020; 21(23):3291-3300.
PMID: 32608153
PMC: 7361271.
DOI: 10.1002/cbic.202000343.
OConnell A, Douam F
Vaccines (Basel). 2020; 8(1).
PMID: 31973073
PMC: 7157703.
DOI: 10.3390/vaccines8010036.
Controlling the Replication of a Genomically Recoded HIV-1 with a Functional Quadruplet Codon in Mammalian Cells.
Chen Y, Wan Y, Wang N, Yuan Z, Niu W, Li Q
ACS Synth Biol. 2018; 7(6):1612-1617.
PMID: 29787233
PMC: 6003876.
DOI: 10.1021/acssynbio.8b00096.
Advances in HIV-1 Vaccine Development.
Gao Y, McKay P, Mann J
Viruses. 2018; 10(4).
PMID: 29614779
PMC: 5923461.
DOI: 10.3390/v10040167.
Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.
Gangadhara S, Kwon Y, Jeeva S, Quan F, Wang B, Moss B
Vaccines (Basel). 2017; 5(4).
PMID: 29257056
PMC: 5748618.
DOI: 10.3390/vaccines5040052.
Synthetic biology approach for the development of conditionally replicating HIV-1 vaccine.
Wang N, Yuan Z, Niu W, Li Q, Guo J
J Chem Technol Biotechnol. 2017; 92(3):455-462.
PMID: 28983143
PMC: 5624719.
DOI: 10.1002/jctb.5174.
Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine.
Wang C, Jiang C, Gao N, Zhang K, Liu D, Wang W
Viruses. 2017; 9(6).
PMID: 28574482
PMC: 5490812.
DOI: 10.3390/v9060135.
Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy.
Mullins J, Frenkel L
J Infect Dis. 2017; 215(suppl_3):S119-S127.
PMID: 28520966
PMC: 6601388.
DOI: 10.1093/infdis/jiw636.
Expression of complete SIV p27 Gag and HIV gp120 engineered outer domains targeted by broadly neutralizing antibodies in live rubella vectors.
Virnik K, Nesti E, Dail C, Hockenbury M, Ni Y, Felber B
Vaccine. 2017; 35(24):3272-3278.
PMID: 28483193
PMC: 7886187.
DOI: 10.1016/j.vaccine.2017.04.047.
Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection.
Adnan S, Reeves R, Gillis J, Wong F, Yu Y, Camp J
PLoS Pathog. 2016; 12(12):e1006104.
PMID: 27959961
PMC: 5189958.
DOI: 10.1371/journal.ppat.1006104.
Reproducing SIVΔnef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines.
Voss J, Macauley M, Rogers K, Villinger F, Duan L, Shang L
AIDS. 2016; 30(16):2427-2438.
PMID: 27428745
PMC: 5069161.
DOI: 10.1097/QAD.0000000000001199.
Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques.
Jensen K, Nabi R, Van Rompay K, Robichaux S, Lifson J, Piatak Jr M
J Virol. 2016; 90(16):7285-7302.
PMID: 27252535
PMC: 4984660.
DOI: 10.1128/JVI.00481-16.
Tet-On Systems For Doxycycline-inducible Gene Expression.
Das A, Tenenbaum L, Berkhout B
Curr Gene Ther. 2016; 16(3):156-67.
PMID: 27216914
PMC: 5070417.
DOI: 10.2174/1566523216666160524144041.
Rectal HSV-2 Infection May Increase Rectal SIV Acquisition Even in the Context of SIVΔnef Vaccination.
Guerra-Perez N, Aravantinou M, Veglia F, Goode D, Truong R, Derby N
PLoS One. 2016; 11(2):e0149491.
PMID: 26886938
PMC: 4757571.
DOI: 10.1371/journal.pone.0149491.
Mucosal Humoral Immune Response to SIVmac239∆nef Vaccination and Vaginal Challenge.
Zeng M, Smith A, Shang L, Wietgrefe S, Voss J, Carlis J
J Immunol. 2016; 196(6):2809-18.
PMID: 26864031
PMC: 4779663.
DOI: 10.4049/jimmunol.1500156.
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).
Fuchs J, Frank I, Elizaga M, Allen M, Frahm N, Kochar N
Open Forum Infect Dis. 2015; 2(3):ofv082.
PMID: 26199949
PMC: 4504730.
DOI: 10.1093/ofid/ofv082.
HIV vaccine research: the challenge and the way forward.
Wang H, Mo Q, Yang Z
J Immunol Res. 2015; 2015:503978.
PMID: 25861656
PMC: 4377490.
DOI: 10.1155/2015/503978.